Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial)

Peer Review reports

Original Submission
10 Oct 2013	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
15 Oct 2013	Author responded	Author comments - Alfredo Budillon
Resubmission - Version 3
15 Oct 2013	Submitted	Manuscript version 3
Publishing
13 Nov 2014	Editorially accepted
24 Nov 2014	Article published	10.1186/1471-2407-14-875

Back to article page